Our experience of Dupilumab and maintenance oral corticosteroid use in severe adult atopic dermatitis associated to severe asthma.

Conclusions: Dupilumab is effective in improving AD unresponsive to conventional therapy in patients with severe asthma and resulted in the reduction of OCS without interference with the control of asthma symptoms.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Airway pharmacology and treatment Source Type: research